Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation - Test2 - elhamkhani - TriplyDB

Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation

Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation

http://www.wikidata.org/entity/Q24289051

about

sameAs

Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases Enhancement of CIITA transcriptional function by ubiquitin Expression regulation of major histocompatibility complex class I and class II encoding genes Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid MHC class II transactivator represses human IL-4 gene transcription by interruption of promoter binding with CBP/p300, STAT6 and NFAT1 via histone hypoacetylation Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A.Regulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expression Stable protein, unstable plaque?ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene transcription Regulation of major histocompatibility complex class II genes Class II histone deacetylases confer signal responsiveness to the ankyrin-repeat proteins ANKRA2 and RFXANK.Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator Interferon gamma repression of collagen (COL1A2) transcription is mediated by the RFX5 complex Impaired chromatin remodelling at STAT1-regulated promoters leads to global unresponsiveness of Toxoplasma gondii-infected macrophages to IFN-γ Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.Novel functions for TAF7, a regulator of TAF1-independent transcription.Histone deacetylase regulation of immune gene expression in tumor cells.Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription.CATERPILLERs, pyrin and hereditary immunological disorders.Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity.Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection.RFXB and its splice variant RFXBSV mediate the antagonism between IFNgamma and TGFbeta on COL1A2 transcription in vascular smooth muscle cells.Histone deacetylases and the immunological network: implications in cancer and inflammation.NF-Y and the transcriptional activation of CCAAT promoters.Modulation of antigen-presenting cells by HDAC inhibitors: implications in autoimmunity and cancer.HDAC inhibitor-based therapies: can we interpret the code?The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.EBP1 and DRBP76/NF90 binding proteins are included in the major histocompatibility complex class II RNA operon.Oct-1 maintains an intermediate, stable state of HLA-DRA promoter repression in Rb-defective cells: an Oct-1-containing repressosome that prevents NF-Y binding to the HLA-DRA promoter.Epigenetics and miRNA during bacteria-induced host immune responses.Mycobacterium tuberculosis EsxL inhibits MHC-II expression by promoting hypermethylation in class-II transactivator loci in macrophages.Histone deacetylases function as a novel potential therapeutic target for cancer.Metastatic melanoma cells evade immune detection by silencing STAT1.Histone deacetylase inhibitors activate CIITA and MHC class II antigen expression in diffuse large B-cell lymphoma.CIITA mediates interferon-gamma repression of collagen transcription through phosphorylation-dependent interactions with co-repressor molecules.Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression.Sequential modifications in class II transactivator isoform 1 induced by lipopolysaccharide stimulate major histocompatibility complex class II transcription in macrophages.Regulation of acetylation at the major histocompatibility complex class II proximal promoter by the 19S proteasomal ATPase Sug1.

P2860

Q22330787-B8EC3C54-1196-4D5C-B724-C793B9B8BE35 Q22330788-AB72BB35-FF4F-4FBA-A3A9-F54CFAC10E54 Q22330796-2AC009E7-F418-4C53-96A8-F74146FF60D2 Q24273365-0266A58D-D7D6-4D39-86BC-C7586B490437 Q24288944-1F408661-3B67-40AD-898F-2889F9899EC7 Q24289144-5C67CC2F-71DE-4D09-B45F-22C822695E24 Q24289180-FB860E4C-5B8A-425D-A81B-16850061606F Q24289242-0D0DBCC7-CE67-4FD2-BAC5-EDA3FEA2EC5F Q24289391-8481FA93-F00D-469B-8769-AA68499734FD Q24289418-66C80E67-C6A3-493C-AF18-51C2AFBAE630 Q24289448-8703F020-7A13-4749-8269-D0C9DEC15AAD Q24338643-46021C3F-8674-43CF-B73B-FFBC10FD2A7B Q24652921-F400FC13-C983-42C6-940B-2B63F5D2F46E Q28206220-9EB71B58-6E40-4423-8E50-686EFF476EC8 Q34139953-2B4F4C64-494C-48FE-A13F-5FDEC62608C3 Q34259906-D2CB3979-DEB0-491D-94BC-25993D101D73 Q34385864-E4F424FD-26C4-41A4-925B-EE2C88E208A9 Q35092304-E7DD4FFF-8D08-4F32-87ED-617EC74943B3 Q35136002-2641CC6E-371C-447A-85C8-9738074E1E99 Q35780194-6E750F3E-4358-4E11-87A4-29FA359DBFC9 Q36405072-24DE7AB0-68FE-4106-9BD4-7F56DD9CEAEB Q36447938-A2717935-8F8E-4C50-A781-3A594163EACF Q37012515-2F6A3B89-19F2-4AA4-A5D2-543C40B616FE Q37273654-53527FD2-1E06-4229-B4B4-80DAE2B0C084 Q37621256-DEAE73AD-E772-4E1B-A5A7-5A174A9DE1EC Q37952284-1A274BF8-B395-483F-B16B-34E2658CFF4D Q37959304-BBC35F83-BE26-46EE-A095-92AA1ABBA0C1 Q38058971-52EE99B1-33D0-4027-B53C-93FC86245746 Q38132389-F2FB18C8-3647-45FC-8DB8-406C2D8B5363 Q38318899-66BBC11F-9A13-44C8-A011-CCA48C0CE251 Q38342092-A39DEE3F-ECD9-42A7-B7B6-7F1DABB45516 Q38639010-84A75A51-12DB-4AD8-852F-DDA9E433468F Q38716100-2BEC62EC-FA17-4F6B-B701-CC1F4E65880F Q38908331-B67D5847-CC6A-40CD-9979-9080E5DB9F06 Q38908693-37A3F963-33D2-4BB1-85AA-37112CE5B3B1 Q39136897-7B1CEDF8-3F8E-4158-B060-9BC45A9FE73C Q40054485-59CFF14C-D83B-4AB3-A8D0-61C35C8AD590 Q40111521-EAC33D60-C98F-4874-833F-B2AC84143B3A Q40210146-35EAB666-6C18-49C0-B892-B2EB5325CA7C Q42233761-247E89C5-081D-483F-8F29-B7D06B253BEE

P2860

Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation

http://www.wikidata.org/entity/Q24289051

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@ast

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en-gb

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@nl

type

label

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@ast

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en-gb

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@nl

altLabel

Histone Deacetylase 1/mSin3A D ...... lass II Enhanceosome Formation

@en

prefLabel

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@ast

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en-gb

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@nl

P1433

Q24289051-BE0C9E44-9F8F-4E9F-A0B8-1C9641F11C33

P1476

Q24289051-A20A0C0B-87C1-4210-8C60-D33C139673F9

P2093

Q24289051-41AB2238-8443-41F3-9AAA-CA85DF08A690

Q24289051-C08710FE-99D2-4975-A1C0-CF706B0B53A4

Q24289051-D0C46616-8ACC-4CEA-A1B5-9243167A4137

Q24289051-FEADCAA5-EBB0-4E43-B633-F65D586F7C80

P2860

Q24289051-037F7026-4BC4-4B5F-82F4-0121C677ED1C

Q24289051-18FB1FF3-3376-4452-89FB-3D296687B8DF

Q24289051-20102DF4-51B9-4117-B079-991027D2A8A4

Q24289051-2124CD39-D980-4497-B83A-FA0AAA1CA823

Q24289051-2E602BD8-C74F-4BAA-B452-193155481F4F

Q24289051-36A2B150-955C-4CFC-BE58-D98FC0233D3A

Q24289051-3E0214C5-A119-43E2-8249-2886F46BAB16

Q24289051-3FFD0D14-9B92-4107-9B92-BC260ADD2E46

Q24289051-47070F97-3D15-4AF5-8556-71BE72B74C23

Q24289051-4F13AC28-A24B-4B67-BFE7-A0D80BBDEA60

P304

Q24289051-A4F9D38D-E063-4B8E-8E00-791810519EA4

P31

Q24289051-037594E1-F494-4F38-8C5B-84E6FA8A614F

P356

Q24289051-B0700D1F-2179-48BC-8AD8-9F706886EFFA

P407

Q24289051-FF0B299F-FB88-4C13-BB3F-45F9FD227908

P433

Q24289051-644A10CA-9800-432A-88AB-3765264DC831

P478

Q24289051-E3C3D581-1C2C-4ABA-96C9-ED53F7E175FA

P50

Q24289051-DC52D6F0-0BE5-4C5C-A3B3-515AB9985861

P577

Q24289051-F0B64450-09D9-4EB1-9A83-3982A3BF477F

P698

Q24289051-290CAAC3-9FB1-4A02-9FDE-386FF86D704E

P921

Q24289051-B8A7D230-B165-4B9E-92A3-9A515EFF254F

P932

Q24289051-91429365-58CE-44FC-96E1-91AE90B1A9FE

P356

MCB.23.9.3091-3102.2003

P1433

Molecular and Cellular Biology

P1476

Histone deacetylase 1/mSin3A d ...... lass II enhanceosome formation

@en

P2093

Eleni Zika

http://www.w3.org/2001/XMLSchema#string

Jenny P-Y Ting

http://www.w3.org/2001/XMLSchema#string

Susanna F Greer

http://www.w3.org/2001/XMLSchema#string

Xin-Sheng Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation

Histone deacetylases specifically down-regulate p53-dependent gene activation

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA)

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32

The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression

CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation

Class II transactivator: mastering the art of major histocompatibility complex expression

Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3

P304

3091-3102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/MCB.23.9.3091-3102.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12697811

http://www.w3.org/2001/XMLSchema#string

P921

P932

153210

http://www.w3.org/2001/XMLSchema#string